Trials / Recruiting
RecruitingNCT06685211
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
A Randomized, Sham Controlled, Masked Study to Evaluate the Efficacy of Alternating Current Stimulation Using the Eyetronic System for the Treatment of Glaucoma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the efficacy, transorbital alternating current stimulation (rtACS) using the EYETRONIC for the treatment in patients with glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Eyetronic rtACS | The repetitive, transorbital alternating current stimulation (rtACS) is a device for non-invasive Interventional Neurophysiology. The electrical charge and current density applied during rtACS safe and able to modulate existing neuronal elements in the eye and brain. |
| DEVICE | Sham rtACS | Participants will wear the Eyetronic system but there will be no active stimulations applied. |
Timeline
- Start date
- 2025-07-14
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2024-11-12
- Last updated
- 2025-11-04
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06685211. Inclusion in this directory is not an endorsement.